Design Therapeutics Expands Board of Directors with Key Appointments
June 07, 2021 16:05 ET | Source: Design Therapeutics, Inc. Design Therapeutics, Inc. Solana Beach, California, UNITED STATES
CARLSBAD, Calif., June 07, 2021 (GLOBE NEWSWIRE) Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for degenerative genetic disorders, today announced the appointments of industry veterans, Heather Behanna, Ph.D., principal of SR One, and Deepa Prasad, managing director of WestRiver Group, to its board of directors effective June 15, 2021.
“We are delighted to further strengthen the Design team with the appointments of both Heather and Deepa to our board of directors, who bring a wealth of experience and insights in corporate and financial strategy and biotechnology company growth,” said João Siffert, M.D., president and chief executive officer of Design Therapeutics. “Over the course of 202
Design Therapeutics Expands Board of Directors with Key Appointments streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.